As of Feb 16
| -0.05 / -0.34%|
The 4 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 16.00, with a high estimate of 17.00 and a low estimate of 11.00. The median estimate represents a +10.34% increase from the last price of 14.50.
The current consensus among 7 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.